Gareth Macdonald

Latest from Gareth Macdonald

Quality gene therapies require quality analytics
Therapeutic Class
Quality gene therapies require quality analyticsQuality gene therapies require quality analytics
byGareth Macdonald
Oct 27, 2021
3 Min Read
Room for both allogeneic and autologous in cell therapy space
Therapeutic Class
Room for both allogeneic and autologous in cell therapy spaceRoom for both allogeneic and autologous in cell therapy space
byGareth Macdonald
Oct 19, 2021
4 Min Read

All from Gareth Macdonald

How biopharma dealt with COVID: ‘We science-ed the crap out of it!’
Global Markets
How biopharma dealt with COVID: ‘We science-ed the crap out of it!’
How biopharma dealt with COVID: ‘We science-ed the crap out of it!’
Oct 11, 2021
|
2 Min Read
byGareth Macdonald
FDA: Drug firms using 24/7 production need more viral safety data
Regulations
FDA: Drug firms using 24/7 production need more viral safety data
FDA: Drug firms using 24/7 production need more viral safety data
Sep 2, 2021
|
2 Min Read
byGareth Macdonald
eBook: Cell and Gene Therapies &mdash; <br>A 2021 Industry Update
Therapeutic Class
eBook: Cell and Gene Therapies — A 2021 Industry Update
eBook: Cell and Gene Therapies — A 2021 Industry Update
Aug 25, 2021
+2
byDan Stanton, Gareth Macdonaldand 2 more
UK group says 3D printed automated control tech can cut mAb production costs
Upstream & Downstream Processing
UK group says 3D printed automated control tech can cut mAb production costs
UK group says 3D printed automated control tech can cut mAb production costs
Aug 23, 2021
|
4 Min Read
byGareth Macdonald
Thermo: Cell & gene therapy key to further growth in 2021
Upstream & Downstream Processing
Thermo: Cell & gene therapy key to further growth in 2021
Thermo: Cell & gene therapy key to further growth in 2021
Aug 5, 2021
|
3 Min Read
byGareth Macdonald
Ring raises $117m to fund development of anellovectors
Facilities & Capacity
Ring raises $117m to fund development of anellovectors
Ring raises $117m to fund development of anellovectors
Aug 4, 2021
|
2 Min Read
byGareth Macdonald
Thermo takes aim at growing plasmid DNA manufacturing market with new plant
Facilities & Capacity
Thermo takes aim at growing plasmid DNA manufacturing market with new plant
Thermo takes aim at growing plasmid DNA manufacturing market with new plant
Jul 20, 2021
|
2 Min Read
byGareth Macdonald
Bluebird resumes Zynteglo sales after positive EMA committee review
Regulations
Bluebird resumes Zynteglo sales after positive EMA committee review
Bluebird resumes Zynteglo sales after positive EMA committee review
Jul 16, 2021
|
3 Min Read
byGareth Macdonald
US FDA aims to clarify reporting rules for biologics CMC changes
Regulations
US FDA aims to clarify reporting rules for biologics CMC changes
US FDA aims to clarify reporting rules for biologics CMC changes
Jun 28, 2021
|
2 Min Read
byGareth Macdonald
Eisai and BMS in $650m solid tumor ADC pact
Deal-Making
Eisai and BMS in $650m solid tumor ADC pact
Eisai and BMS in $650m solid tumor ADC pact
Jun 21, 2021
|
2 Min Read
byGareth Macdonald
Vor building cell therapy plant to support clinical trials
Facilities & Capacity
Vor building cell therapy plant to support clinical trials
Vor building cell therapy plant to support clinical trials
Jun 21, 2021
|
2 Min Read
byGareth Macdonald
Enzymatic DNA printer will speed R&D and COVID testing, says DNA Script
Upstream & Downstream Processing
Enzymatic DNA printer will speed R&D and COVID testing, says DNA Script
Enzymatic DNA printer will speed R&D and COVID testing, says DNA Script
Jun 18, 2021
|
2 Min Read
byGareth Macdonald
Avalon to buy China’s Senlang for cell therapy pipeline and manufacturing plant
Deal-Making
Avalon to buy China’s Senlang for cell therapy pipeline and manufacturing plant
Avalon to buy China’s Senlang for cell therapy pipeline and manufacturing plant
Jun 16, 2021
|
2 Min Read
byGareth Macdonald
COVID-19 driven CDMO investments to benefit wider sector
Global Markets
COVID-19 driven CDMO investments to benefit wider sector
COVID-19 driven CDMO investments to benefit wider sector
Jun 14, 2021
|
3 Min Read
byGareth Macdonald
Back to business? Demand for trials returning, says Icon
Global Markets
Back to business? Demand for trials returning, says Icon
Back to business? Demand for trials returning, says Icon
Jun 7, 2021
|
3 Min Read
byGareth Macdonald
UPenn gene therapy researchers lease space at Discovery Labs
Facilities & Capacity
UPenn gene therapy researchers lease space at Discovery Labs
UPenn gene therapy researchers lease space at Discovery Labs
May 27, 2021
|
2 Min Read
byGareth Macdonald
Engineering Alternatives: Modern Technology Enables Expression System Developers to Think Beyond CHO Cells
Expression Platforms
Engineering Alternatives: Modern Technology Enables Expression System Developers to Think Beyond CHO Cells
Engineering Alternatives: Modern Technology Enables Expression System Developers to Think Beyond CHO Cells
May 24, 2021
+3
byGareth Macdonald, Cheryl Scottand 3 more
Bluebird welcomes CHMP nod for CALD gene therapy
Regulations
Bluebird welcomes CHMP nod for CALD gene therapy
Bluebird welcomes CHMP nod for CALD gene therapy
May 24, 2021
|
2 Min Read
byGareth Macdonald
Thermo teams with UCSF on San Fran cell therapy center
Facilities & Capacity
Thermo teams with UCSF on San Fran cell therapy center
Thermo teams with UCSF on San Fran cell therapy center
May 21, 2021
|
2 Min Read
byGareth Macdonald
Canada pays $164 million to add Resilience to pandemic prep effort
Bioprocess Insider
Canada pays $164 million to add Resilience to pandemic prep effort
Canada pays $164 million to add Resilience to pandemic prep effort
May 20, 2021
|
2 Min Read
byGareth Macdonald
Charles River to boost CDMO offering through $300m Vigene acquisition
Deal-Making
Charles River to boost CDMO offering through $300m Vigene acquisition
Charles River to boost CDMO offering through $300m Vigene acquisition
May 18, 2021
|
2 Min Read
byGareth Macdonald
Merck: COVID-related work helped German firm grow revs in Q1
Upstream & Downstream Processing
Merck: COVID-related work helped German firm grow revs in Q1
Merck: COVID-related work helped German firm grow revs in Q1
May 17, 2021
|
2 Min Read
byGareth Macdonald
CDMOs need to invest in innovation to make complex meds, says Resilience CEO
Global Markets
CDMOs need to invest in innovation to make complex meds, says Resilience CEO
CDMOs need to invest in innovation to make complex meds, says Resilience CEO
May 14, 2021
|
3 Min Read
byGareth Macdonald
Laronde aims to turn cells into drug production facilities using eRNA
Therapeutic Class
Laronde aims to turn cells into drug production facilities using eRNA
Laronde aims to turn cells into drug production facilities using eRNA
May 11, 2021
|
2 Min Read
byGareth Macdonald
Charles River sets sights on cell therapy manufacturing after Cognate buy
Therapeutic Class
Charles River sets sights on cell therapy manufacturing after Cognate buy
Charles River sets sights on cell therapy manufacturing after Cognate buy
May 7, 2021
|
2 Min Read
byGareth Macdonald
Biosimilars: Roche and Biogen talk competition, price, opportunities
Global Markets
Biosimilars: Roche and Biogen talk competition, price, opportunities
Biosimilars: Roche and Biogen talk competition, price, opportunities
Apr 27, 2021
|
3 Min Read
byGareth Macdonald
Autologous therapy firms should use tech to cut COGS, says expert
Therapeutic Class
Autologous therapy firms should use tech to cut COGS, says expert
Autologous therapy firms should use tech to cut COGS, says expert
Apr 23, 2021
|
3 Min Read
byGareth Macdonald
Oxford Biomedica working to optimize vector production platform
Upstream & Downstream Processing
Oxford Biomedica working to optimize vector production platform
Oxford Biomedica working to optimize vector production platform
Apr 20, 2021
|
2 Min Read
byGareth Macdonald
Preparation key to gene therapy commercialization, MilliporeSigma
Therapeutic Class
Preparation key to gene therapy commercialization, MilliporeSigma
Preparation key to gene therapy commercialization, MilliporeSigma
Apr 19, 2021
|
2 Min Read
byGareth Macdonald
Thermo Fisher to buy PPD to build in ‘high growth’ clinical services sector
Deal-Making
Thermo Fisher to buy PPD to build in ‘high growth’ clinical services sector
Thermo Fisher to buy PPD to build in ‘high growth’ clinical services sector
Apr 19, 2021
|
2 Min Read
byGareth Macdonald
BPI West: Modular tech key to rapid COVID-19 vaccine development
Upstream & Downstream Processing
BPI West: Modular tech key to rapid COVID-19 vaccine development
BPI West: Modular tech key to rapid COVID-19 vaccine development
Apr 16, 2021
|
2 Min Read
byGareth Macdonald
Resilience adds CDMO Ology to growing manufacturing footprint
Facilities & Capacity
Resilience adds CDMO Ology to growing manufacturing footprint
Resilience adds CDMO Ology to growing manufacturing footprint
Apr 13, 2021
|
3 Min Read
byGareth Macdonald
CGT firms making progress but manufacturing remains a hurdle, says analyst
Therapeutic Class
CGT firms making progress but manufacturing remains a hurdle, says analyst
CGT firms making progress but manufacturing remains a hurdle, says analyst
Apr 12, 2021
|
2 Min Read
byGareth Macdonald

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Thermo Fisher WP
Sponsored Content
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells

Nov 21, 2024